5 May 2016

Sinclair IS Pharma cuts loss 

22/09/11 Robert Tyerman

Recently-merged Sinclair IS Pharma (SPH.L) has cut annual losses 31 per cent to £11.7 million and launched an Asia-Pacific marketing drive. The AIM-quoted company, which specialises in oral health, dermatology and wound care, increased turnover 19 per cent to nearly £33 million in the year to June.

Steered by entrepreneurial chief executive Chris Spooner, Sinclair, whose losses before exceptional items rose 14.5 per cent to £5.8 million, achieved several product launches last year. The company introduced its Autopiclair eczema and dermatitis cream into France, a market which returned to growth last year with a 21 per cent turnover gain to £12.5 million, and took its Kelo-cote scar reduction formulation into several European markets.

Outgoing chairman John Gregory says the merger of Sinclair Pharma with IS Pharma should lead to annual cost savings of £1 million and has already started to pay off more positively, as with a marketing agreement for the company's Episil treatment for oral mucositis pain. Grahame Cook, already a Sinclair director, will now chair the company, which has already launched two dermatology products in seven Asia-Pacific countries under its partnership with Singapore-based Invida Holdings, a leader in commercialising bio-pharmaceutical and healthcare products in the region.

Sinclair, which ended the financial year with £5 million cash, now has a 'bio-film busting' mouthwash for sale in the USA under the PerioShield banner through an agreement with Sunstar Americas and has several new products in the pipeline. Highlighted by Growth Company Investor at 28p last autumn, Sinclair shares have eased to 24p, valuing the company at £93.3 million, but could still outperform some sector peers over the medium term.

Tags: AIM market, Asia-Pacifuyc, Autopiclair, Chris Spooner, Dermatology, Wound care

Cash Shells 2015

Published in September 2015 this annual research report provides a comprehensive overview of cash shells on the Main Market, AIM and PLUS landscape. Order your copy today

 

Superb investment toolkit for private investors

SharePad is the new web-based service from ShareScope. Easier to use and more powerful. Perfect for tablets, Macs and Windows PC. Covers ALL your investment requirements.

Growth Company Investor: free trial

Since 2008, our share tips outperformed the benchmark by 281%. Take a free trial and get access to our recommendations today. Start free trial now.

Directors' Pay on AIM 2015

The most comprehensive review of AIM directors' pay available, and this year includes a record sample of 1000+ AIM-quoted companies. The full report is available to order for £385 + VAT. Click here for more info

 

Latest small-cap and growth company news

Daily coverage of small-cap company stocks on London's junior markets AIM and PLUS, breaking news, stock research and latest share price information for investors. Full sector coverage with all the latest news on smaller listed companies, updated several times a day with financial reports, trading statements and links to further web resources.

Popular News

Latest News

'The most exciting retail opportunity on the landscape' 02/05/16

Last year Noel Collett made an unconventional career move. He’d spent sixteen years at the leading discount supermarket Lidl, where as UK Chief Operating Officer he oversaw its growth into a £4.5 billion 600 store giant. So his move to Crawshaws (AIM: CRAW) as CEO was as far removed from Lidl as he could possibly get. However he describes Crawshaws as ‘the most exciting retail opportunity on the landscape'.

Seeking Inspiration in neonatal care  29/04/16

Inspiration Healthcare (AIM: IHC) has turned the usual development pattern for small medical technology companies on its head. Unlike typical small companies in the sector, it's already profitable with a cash generative distibution arm. It's aim now is to start pushing its own products through that pipeline.

GB going great guns 22/04/16

GB Group (AIM: GBG) has released a positive update on trading for the year to March. Operating profits are comfortably ahead of expectations and show 24 per cent growth. What’s slightly unsettling, especially given the demanding prospective p/e ratio of 30, is the news that long-time CEO Richard Law is to step down.

Looking after the talent 21/04/16

NetDimensions (AIM: NETD) shares enjoyed a strong recovery in the years following the financial crisis, only to run out of steam last summer. The subsequent 40 per cent fall in the share price looks like it’s now played out, with the stock responding well to recent results.

The Tide is rising 21/04/16

Crimson Tide (AIM: TIDE) is a tiny tech company with only £1.4 million sales just reported for the 2015 year. However it’s highly unusual for its size in that it’s profitable and generates cash. Sales are forecast to grow to £2.4 million next year and if this momentum can be built on, the shares could get interesting.

Mi-Pay moving the right way 14/04/16

Mi-Pay (AIM: MPAY) has announced results which show reduced losses and evidence that things are moving in the right direction. The company provides payment services for mobiles; so it’s certainly exposed to a growing markets. Costs and cash outflows have been reduced, while the value of customer transactions grew by 31 per cent in 2015.

More News